TradingAgents AISign inGet started
All stock profiles
CNCNYSEHealthcare

CENTENE CORP

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$68.45

-0.25%

Alpha Vantage · 10/30/2026

Industry: Healthcare PlansCategory: Domestic Common StockCurrency: USDNews: 3 recent
Analyze CNC free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

+12.2%

3 months

+7.4%

6 months

+28.3%

1 year

+95.5%

Year to date

+66.3%

52-week range

$31.80 – $71.24

Fundamental snapshot

Latest reported period: Sep 30, 2026

Sharadar reported data

Market cap

$33.89B

P/E

23.2

P/B

1.5

P/S

0.2

Revenue

$203.9B

Net income

$1.46B

Diluted EPS

2.92

Gross margin

7.80%

Net margin

0.70%

Return on equity

6.80%

Total debt

$15.54B

Cash

$20.7B

Free cash flow

$3.94B

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Sep 30, 2026$50.65B-$71M6.40%-0.10%-$3.86B
Jun 30, 2026$53.58B$1.09B8.60%2.00%$3.42B
Mar 31, 2026$49.94B$1.54B11.10%3.10%$4.17B
Dec 31, 2025$49.73B-$1.1B5.00%-2.20%$224M
Sep 30, 2025$49.69B-$6.63B6.50%-13.30%$1.15B
Jun 30, 2025$48.74B-$253M6.00%-0.50%$1.58B
Mar 31, 2025$46.62B$1.31B11.20%2.80%$1.38B
Dec 31, 2024$40.81B$283M9.10%0.70%-$741M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent CNC news

All market news
Healthcare Dive·64 signal
CVS sues to prevent $2B Medicare Advantage star ratings hit

CVS Health is suing the federal government to challenge its 2027 Medicare Advantage star ratings, aiming to avert a potential revenue loss exceeding $2 billion due to declining quality scores. The lawsuit argues that the CMS used illegal methodology and improperly adopted measures to calculate the ratings. CVS joins at least four other insurers in similar lawsuits, all citing a previous ruling that found CMS measures for 2026 scores to be illegal.

Original source